Login to Your Account



Other News To Note


Monday, January 14, 2013
• Evotec AG, of Hamburg, Germany, said a compound identified and optimized in a research collaboration with Osaka, Japan-based Ono Pharmaceutical Co. Ltd. was nominated to enter preclinical development, leading to the payment of an undisclosed milestone.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription